WO2026008693A1 - Method for preparing 4-amino-furane - Google Patents
Method for preparing 4-amino-furaneInfo
- Publication number
- WO2026008693A1 WO2026008693A1 PCT/EP2025/068821 EP2025068821W WO2026008693A1 WO 2026008693 A1 WO2026008693 A1 WO 2026008693A1 EP 2025068821 W EP2025068821 W EP 2025068821W WO 2026008693 A1 WO2026008693 A1 WO 2026008693A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compounds
- methyl
- coor
- radicals
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
The present invention relates to a novel method for preparing 4-amino-furanes of the general formula (I) and salts thereof.
Description
Method for preparing 4-amino-furane
The present invention relates to a novel method for preparing 4-amino-furanes of the general formula (I) and salts thereof.
4-Amino-furanes of the general formula (I) (especially R1= COOMe) are important precursors of agrochemical active ingredients (cf. WO2018/228985) and pharmaceutical active ingredients (e.g. DNA binding agents: Woods, Craig R. et al. Bioorganic & Medicinal Chemistry Letters, 12(18), 2647-2650; 2002).
4-Amino-furanes of the general formula (I) serve as starting material for the preparation of tetrahydro- and dihydrofurane carboxylic acids and esters. To date, these compounds of the formula (I) have been prepared by a multi-stage synthesis including a bromination, dehalogenation, coupling reaction and deprotection, (see F. Brucoli, et al. Bioorganic & Medicinal Chemistry, 20(6), 2019-2024; 2012).
Scheme 1:
Br2, AICL: b) Zn, NFLCl; c) Cui/ (CfLNHCfL):. Boc-NFL, K2CO3 d) removal of Boc protecting group
The synthesis mentioned above has a large number of disadvantages, such as low atom economy (bromination and dehalogenation), use of heavy metals such as zinc and use of protecting groups such as Boc -amine. The method described in Bioorganic & Medicinal Chemistry, 20(6), 2019-2024; 2012 furthermore requires the use of metal-containing (for example copper(I) iodide) catalysts.
These disadvantages render the method for preparing compounds of the general formula (I) uneconomic and therefore very expensive.
F. Wolter et al in (Organic Letters, 11(13), 2804-2807; 2009) describes another method for preparing aminofurans of the general formula (I), specifically via a Curtins rearrangement of dimethyl furan-2,4-
dicarboxylate using (PhCfEPiOjN;. This method is unsuitable for industrial applications due to the highly explosive properties of organic azides.
Several compounds of the general formula (I), for example where R1= CF3 and R2 = NHAryl, have been described in European Journal of Organic Chemistry 2018, 3853-3861. However, this compound was detected in a mixture of several components.
WO 2022/018057 describes a synthesis in the presence of a dehydrating reagent which can be used on industrial scale, e.g. thionyl chloride, oxalyl chloride or phosphorous oxychloride. However, these dehydrating reagents have different disadvantages for the process and in addition for product of the general formula (I).
The disadvantage of thionyl chloride is the presence of sulphur in the product - the compounds of the general formula (I) - which poisons catalysts in further reactions. As the compound of formula (I) is an important precursor of agrochemical and pharmaceutical active ingredients it is often further reacted, and this disadvantage is of major importance.
The disadvantage of oxalyl chloride is the moderate yield, higher costs of the reagent and potential formation of low solubility by-products which would lead to significantly increased purification requirements.
The use of phosphorous oxychloride would lead to the formation of stoichiometric phosphorous waste which is not environmentally friendly and cause high purification efforts and disposal costs.
In light of the prior art, the object of the present invention is to find a sulphur-free, cost-effective and environmentally friendly method for preparing compound of formula (I) and which is therefore more favourable to be used in industry. It is also desirable to obtain these compounds with high yield and at high purity, such that they do not have to be subjected to any further complex purification.
The object described above - simple, cost-effective, sulphur-free, environmentally friendly and large-scale production - is achieved by a method for preparing compounds of the general formula (I) and salts thereof
in which
R1 is CF3, CF2H, C2F5, CF2CI, CCh, COOR3, COOH,
R2 is H, CH3CO, CCI3CO, CF3CO, phenyl-CO, CH3OCO, (CH3)3COCO, phenyl, phenyl-CH2, (diphenyl)CH,
R3 is (Ci-C4)alkyl, characterized in that compounds of the general formula (II)
with R1 and R2 are as defined above are reacted in the presence of phosgene or triphosgene to give compounds of the general formula (I).
Preferred definitions of the radicals of the compounds of the general formulae (I), (II) are as follows:
R1 is CF3, CF2H, CF2CI, C2F5, CCI3, COOR3,
R2 is H, CF3CO, CH3CO, CCI3CO, phenyl, phenyl-CH2, (diphenyl)CH, CH3OCO, (CH3)3COCO,
R3 is Methyl, Ethyl.
Particularly preferred definitions of the radicals of the compounds of the general formulae (I), (II) are as follows:
R1 is CF3, CF2H, CCI3, COOR3,
R2 is H, COCF3, COCH3, COCCI3, Ph-CIE, (diphenyl)CH, CH3OCO, (CH3)3COCO,
R3 is Methyl, Ethyl.
Especially preferred definitions of the radicals of the compounds of the general formulae (I), (II) are as follows:
R1 is CF3, COOR3,
R2 is H, COCF3, (CH3)3COCO,
R3 is Methyl, Ethyl.
Further especially preferred definitions of the radicals of the compounds of the general formulae (I), (II) are as follows:
R1 is COOR3,
R2 is H,
R3 is Methyl, Ethyl.
Further
definitions of the radicals of the compounds of the general formulae (I), (II) are as follows:
R1 is COOR3,
R2 is H.
R3 is Methyl.
The reaction sequence for preparing compounds of the formula (I) is shown in Scheme 2:
(II) (I)
Compounds of the formula (II) react with phosgene or triphosgene to form compounds of the general formula (I). The preparation of compounds of the formula (II) are known from WO 2022/018057.
Compounds of the formula (II) are cyclized. The ring closure takes place in the presence of a dehydrating reagent phosgene or triphosgene.
Compounds of the formula (I) are formed in the form of HC1 salts thereof.
If the compounds of the general formula (I) are obtained in the form of salts thereof, for example as a hydrochloride, the salt-free forms can be obtained by treating the salt with a base, for example triethylamine (see also WO 2022/018057).
The molar ratio of the compound of the formula (II) to the cyclization reagent is in the range of about 1:0.1 to 1:5, preferably from 1:0.5 to 1:3.
The reaction is usually carried out in a temperature range of -10°C to 40°C and optionally in the presence of a solvent or diluent. The reaction is preferably carried out in a solvent at -5 °C to 20 °C.
Preferred solvents are toluene, xylenes, chlorobenzene, R3OCOOR3 or R30H (if R1 = COOR3 in which R3 is (Ci-C4)alkyl), or mixtures thereof.
If R1 is an ester, the respective solvent is determined by the type of ester in the final product, e.g: dimethyl carbonate or methanol as solvent finally refers to COOMe.
Especially preferred solvents are toluene, xylenes, dimethyl carbonate and methanol or mixtures thereof.
Description of the method
Examples
The present invention is elucidated in more detail by the examples which follow, without restricting the invention to these examples.
Method of measurement
The products were characterized by ’H NMR spectroscopy and/or HPLC.
The NMR spectra were determined using a Bruker Avance II 600.
The product assay determination by quantitative HPLC were measured on an Agilent Technologies HP 1100 using Zorbax Eclipse 5 XDB-C8 column (150*4.6 mm) and acetonitrile, aqueous buffer gradient. Methyl 4-aminofuran-2-carboxylate hydrochloride (prepared, purified as analytical sample) was used as references substance.
Example 1
Methyl 4-aminofuran-2-carboxylate hydrochloride (salt of formula (I)) using triphosgene
20 g (95.4 wt.%, 120 mmol, 1.0 eq) of methyl 4-amino-5-hydroxy-2-oxo-pent-3 -enoate and 50 ml (39.6 g) of methanol were added to a jacketed reactor and the suspension was stirred at 0 °C. A solution of 25.7 g (86.8 mmol, 0.72 eq) triphosgene, dissolved in 80 ml (69.2 g) of toluene, was dosed over 1 h and the
temperature was maintained at 0-5°C. After complete dosing, stirring continued for 19 h at 0 °C. The suspension was filtered, the filter cake washed with 30 ml of a solvent mixture of 11,4 ml (9 g) methanol and 18,6 ml (16,1 g) toluene and dried under reduced pressure. 19.6 g (98.1 wt.%, 90% yield) of the product was obtained as a beige solid.
’H-NMR (600 MHz, d6-DMSO): 5 9.00-11.00 (3H, br.); 8.08 (1H, d); 7.31 (1H, d); 3.83 (3H, s) ppm.
13C-NMR (600 MHz, d6-DMSO): 158.0; 143.6; 140.3; 121.7; 114.8; 112.1; 52.4 ppm.
Example 2
Methyl 4-aminofuran-2-carboxylate hydrochloride (salt of formula (I)) using phosgene
20 g (95.4 wt.%, 120 mmol, 1.0 eq) of methyl 4-amino-5-hydroxy-2-oxo-pent-3-enoate, 50 ml (39.6 g) of methanol and 80 ml (69.2 g) of toluene were added to a jacketed reactor and the suspension was stirred at 0 °C. 30,84 g (311 mmol) phosgene gas were dosed into the suspension through a gas inlet tube over 1 h and the temperature was maintained at 0-5 °C. After complete dosing, stirring continued for 19 h at 0 °C. The suspension was filtered, the filter cake washed two times with 30 ml of a solvent mixture of 11,4 ml (9 g) methanol and 18,6 ml (16,1 g) toluene and dried under reduced pressure. 19.9 g (97,4 wt.%, 91,4% yield) of the product was obtained as a beige solid.
’H-NMR (600 MHz, d6-DMSO): 5 9.00-11.00 (3H, br.); 8.12 (1H, d); 7.33 (1H, d); 3.83 (3H, s) ppm.
Example 3
Methyl 4-aminofuran-2-carboxylate hydrochloride (salt of formula (I)) using triphosgene
In an argon flushed reactor 20 g (94.7 wt.%, 119 mmol, 1.0 eq) of methyl 4-amino-5-hydroxy-2-oxo-pent- 3-enoate were suspended in 39.6 g of Methanol and cooled to 0 °C to 5 °C. To this suspension a solution of 25.7 g (86.8 mmol, 0.72 eq) triphosgene, which was dissolved in 64.1 g of dimethyl carbonate, was added over 1 h and the temperature was maintained at 0-5°C. After complete dosing, stirring was continued for 20 h at 0 °C to 5 °C. Then, the suspension was filtered, the filter cake was washed with dimethyl carbonate and the obtained solid was dried under reduced pressure. 19.7 g (97.6 wt.%, 91% yield) of the product were obtained as a brownish solid.
Example 4
Methyl 4-aminofuran-2-carboxylate hydrochloride (salt of formula (I)) using triphosgene
In an argon flushed reactor 20 g (94.7 wt.%, 119 mmol, 1.0 eq) of methyl 4-amino-5-hydroxy-2-oxo-pent- 3-enoate were suspended in a mixture of 31.7 g Methanol and 7.9 g dimethyl carbonate and cooled to 0 °C to 5 °C. To this suspension a solution of 25.7 g (86.8 mmol, 0.72 eq) triphosgene, which was dissolved in 64.1 g of dimethyl carbonate, was added over 1 h and the temperature was maintained at 0-5°C. After
complete dosing, stirring was continued for 20 h at 0 °C. to 5 °C. Then, the suspension was filtered, the filter cake was washed with dimethyl carbonate and the obtained solid was dried under reduced pressure. 19.9 g (97.58 wt.%, 92% yield) of the product were obtained as a brownish solid.
Example 5
Methyl 4-aminofuran-2-carboxylate hydrochloride (salt of formula (I)) using phosgene
In an argon flushed reactor 20 g (94.7 wt.%, 119 mmol, 1.0 eq) of methyl 4-amino-5-hydroxy-2-oxo-pent- 3-enoate were suspended in a mixture of 47.6 g Methanol and 11,8 g dimethyl carbonate and cooled to 0 °C to 5 °C. To this suspension 29.4 g (297.5 mmol) phosgene gas were dosed through a gas inlet tube over 1 h and the temperature was maintained at 0-5 °C. After complete dosing, stirring was continued for 20 h at 0 °C to 5 °C. Then, the suspension was filtered, the filter cake was washed with dimethyl carbonate and the obtained solid was dried under reduced pressure. 20.1 g (98.7 wt.%, 94% yield) of the product were obtained as a brownish solid.
Example 6
Comparative example:
Methyl 4-aminofuran-2-carboxylate hydrochloride (salt of formula (I)) using thionyl chloride
50.0 g (97 wt.%, 0.3 mol, 1.0 eq) of methyl 4-amino-5 -hydroxy-2 -oxo-pent-3 -enoate were placed in 113 g of methanol and the suspension was cooled to 0 °C. At 0-5 °C, 34. 1 g (0.28 mol, 0.94 eq) thionyl chloride were dosed over 2 h. After complete dosing, stirring continued for 16 h at 0 °C and the suspension was then cooled to -7 °C. The solid was filtered, the filter cake was washed twice at -5 °C with 37 g methanol each and dried. 49.7 g (>99 wt.% (by qHPLC), 92% yield) of the product was obtained as a beige solid. The sulphur content was determined to be 160 ppm by elemental analysis.
Example 7
Comparative example
Methyl 4-aminofuran-2-carboxylate hydrochloride (salt of formula (I)) using oxalyl chloride
82.3 g (94 wt.%, 0.5 mol, 1.0 eq) of methyl 4-amino-5 -hydroxy-2 -oxo-pent-3 -enoate were placed in 330 g of methanol and the suspension was cooled to 0 °C. At 0-5 °C, 86. 1 g (0.52 mol, 1.05 eq) oxalyl chloride, dissolved in 86. 1 g toluene, was dosed over 3 h. After complete dosing, stirring continued for 16 h at 0 °C, the suspension was then heated to 20 °C and stirred at this temperature for 30 min. Finally, the suspension was tempered to -5 °C for 2 h, filtered, the filter cake washed twice at -5 °C with 60 g methanol each and dried. 69.2 g (93.3 wt.% (by qHPLC), 73% yield) of the product was obtained as a beige solid.
Claims
1 . Method for preparing compounds of the general formula (I) and salts thereof,
in which
R1 is CF3, CF2H, C2F5, CF2CI, CCh, COOR3, COOH,
R2 is H, CH3CO, CChCO, CF3CO, phenyl-CO, CH3OCO, (CH3)3COCO, phenyl, phenyl-CH2 (diphenyl)CH,
R3 is (Ci-C4)alkyl, characterized in that compounds of the general formula (II)
with R1 and R2 are as defined above are reacted in the presence of phosgene or triphosgene to give compounds of the general formula (I).
2. Method according to Claim 1, characterized in that the definitions of the radicals of the compounds of the general formulae (I) and (II) are as follows:
R1 is CF3, CF2H, CF2CI, C2F5, CCh, COOR3,
R2 is H, CF3CO, CH3CO, CCI3CO, phenyl, phenyl-CH2, (diphenyl)CH, CH3OCO, (CH3)3COCO,
R3 is Methyl, Ethyl.
3. Method according to Claim 1, characterized in that the definitions of the radicals of the compounds of the general formulae (I) and (II) are as follows:
R1 is CF3, CF2H, CC13, COOR3,
R2 is H, COCF3, COCH3, COCCh, Ph-CH2, (diphenyl)CH, CH3OCO, (CH3)3COCO,
R3 is Methyl, Ethyl.
4. Method according to Claim 1, characterized in that the definitions of the radicals of the compounds of the general formulae (I) and (II) are as follows:
R1 is CF3, COOR3,
R2 is H, COCF3, (CH3)3COCO,
R3 is Methyl, Ethyl.
5. Method according to Claim 1, characterized in that the definitions of the radicals of the compounds of the general formulae (I) and (II) are as follows:
R1 is COOR3
R2 is H,
R3 is Methyl, Ethyl.
6. Method according to Claim 1, characterized in that the definitions of the radicals of the compounds of the general formulae (I) and (II) are as follows:
R1 is COOR3,
R2 is H.
R3 is Methyl.
7. Method according to any of Claims 1 to 6, characterized in that the reaction is carried out at -5 °C to 20 °C.
8. Method according to any of Claims 1 to 7, characterized in that the solvent is toluene, xylenes, dimethyl carbonate and methanol or mixtures thereof.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP24186575.7 | 2024-07-04 | ||
| EP24186575 | 2024-07-04 | ||
| EP25168785 | 2025-04-07 | ||
| EP25168785.1 | 2025-04-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2026008693A1 true WO2026008693A1 (en) | 2026-01-08 |
Family
ID=96344416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP2025/068821 Pending WO2026008693A1 (en) | 2024-07-04 | 2025-07-02 | Method for preparing 4-amino-furane |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2026008693A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9848889B2 (en) | 2010-01-20 | 2017-12-26 | Conventus Orthopaedics, Inc. | Apparatus and methods for bone access and cavity preparation |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018228985A1 (en) | 2017-06-13 | 2018-12-20 | Bayer Aktiengesellschaft | Herbicidally active 3-phenylisoxazoline-5-carboxamides of tetrahydro and dihydrofuran carboxylic acids and esters |
| WO2022018057A1 (en) | 2020-07-23 | 2022-01-27 | Bayer Aktiengesellschaft | Process for preparing aminofuranes |
-
2025
- 2025-07-02 WO PCT/EP2025/068821 patent/WO2026008693A1/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018228985A1 (en) | 2017-06-13 | 2018-12-20 | Bayer Aktiengesellschaft | Herbicidally active 3-phenylisoxazoline-5-carboxamides of tetrahydro and dihydrofuran carboxylic acids and esters |
| WO2022018057A1 (en) | 2020-07-23 | 2022-01-27 | Bayer Aktiengesellschaft | Process for preparing aminofuranes |
| US20230339876A1 (en) * | 2020-07-23 | 2023-10-26 | Bayer Aktiengesellschaft | Process for preparing aminofuranes |
Non-Patent Citations (5)
| Title |
|---|
| EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, 2018, pages 3853 - 3861 |
| F. BRUCOLI ET AL., BIOORGANIC & MEDICINAL CHEMISTRY, vol. 20, no. 6, 2012, pages 2019 - 2024 |
| F. WOLTER ET AL., ORGANIC LETTERS, vol. 11, no. 13, 2009, pages 2804 - 2807 |
| PLA�AIS CLOTILDE ET AL: "Synthesis of 3-Amino-5-fluoroalkylfurans by Intramolecular Cyclization", vol. 23, no. 12, 18 June 2021 (2021-06-18), US, pages 4915 - 4919, XP055843319, ISSN: 1523-7060, Retrieved from the Internet <URL:https://pubs.acs.org/doi/pdf/10.1021/acs.orglett.1c01672> DOI: 10.1021/acs.orglett.1c01672 * |
| WOODSCRAIG R. ET AL., BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 12, no. 18, 2002, pages 2647 - 2650 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9848889B2 (en) | 2010-01-20 | 2017-12-26 | Conventus Orthopaedics, Inc. | Apparatus and methods for bone access and cavity preparation |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2026008693A1 (en) | Method for preparing 4-amino-furane | |
| US6426418B1 (en) | Processes for the manufacturing of 3-hydroxy-N,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide | |
| IL299949A (en) | Process for preparing aminofuranes | |
| US4791210A (en) | Process for the production of 5-methyltetrazole | |
| EP0268820B1 (en) | Process for producing 2-acylfuran derivatives | |
| CN114478300B (en) | Novel acyl chloride catalyst and preparation method and application thereof | |
| US20220009895A1 (en) | N-nitrosaccharins | |
| US6353126B1 (en) | Process for the production of malononitrile | |
| SU677657A3 (en) | Method of producing n-formylated compounds | |
| EP0738720B1 (en) | Process for producing 1-(2-chlorphenyl)-5(4H)-tetrazolinone | |
| US20060247457A1 (en) | Method for the synthesis of methyl-tri-oxo-rhenium | |
| KR870000523B1 (en) | Process for preparing pyrazole herbicide | |
| JPS5840546B2 (en) | 2- Benzimidazole carbamic acid alkyl ester | |
| JP4538993B2 (en) | Process for producing β-ketonitrile derivatives | |
| KR101006737B1 (en) | Method for preparing 2-sulfonyliminoindolin using a copper catalyst | |
| KR0129789B1 (en) | N-Alloyl-C- (N-methylanilino) imidoylchloride derivative and preparation method thereof | |
| EP4477648A1 (en) | Fluoroisoquinoline compound and production method thereof | |
| KR940009935B1 (en) | N-benzoyl-c-thiophenoxyimidoyl chloride derivatives and manufacturing method thereof | |
| JP2003160569A (en) | Method for producing quinazoline derivative using base catalyst | |
| JPH0253764A (en) | Production of dithiobisphenol | |
| JP3355797B2 (en) | Method for producing pyridines having chlorine atom at α-position | |
| JPS5946255A (en) | Method for producing 2-alkoxymethylene-3,3-dialkoxypropanenitrile | |
| PL129167B1 (en) | Process for preparing esters of 3-acylazopropionic acid | |
| JPH05286932A (en) | Production of indoles | |
| JPH09124569A (en) | Method for producing benzamide derivative |